Global Combination Product Services Market Analysis Report 2022-2035 - Rising Need for Effective Drug Delivery in Terms of Controlled Drug Release

News provided by

Feb 14, 2023, 10:20 ET

DUBLIN, Feb. 14, 2023 /PRNewswire/ -- The "Combination Product Services Market by Type of Device Service Focus Area, Company Size, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.

The "Combination Product Services Market 2022-2035" report features an extensive study of service providers engaged in development and testing of combination products. The study features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this domain.

One of the key objectives of the report was to evaluate the existing market size, primary growth factors and future opportunity within the combination product service providers market in the mid to long term. Our year-wise projections of the current and future opportunity within the combination product service providers market have further been segmented across types of devices, service focus areas, company size, and key geographical regions.

Presently, there are several combination product service providers which claim to employ various strategic approaches to support product development and testing to provide safe, effective combination products that meet user needs. These players provide the most suitable characterization methods that help manufacturers throughout the development and manufacturing process.

Some of the common features provided by the combination product service providers include providing access to GMP-certified facilities, larger capacities, new technologies, and greater operational flexibility. Further, in order to address the existing challenges in combination product development and manufacturing, service providers are actively expanding their current geographical reach and broadening their respective services portfolio.

With rising need for effective drug delivery in terms of controlled drug release and the increased focus of service providers towards the development and commercial manufacturing of combination products, the combination product services market is likely to witness a significant growth in the coming years.

Scope of the Report

A detailed company competitiveness analysis of combination product service providers, based on supplier power (based on the experience of the developer in this industry) and service portfolio strength based on several relevant parameters, such as type of combination product(s) (device coated / impregnated with drug, drug delivery device / system, and other types of combination products), type of device(s) (autoinjectors, pen-injectors, prefilled syringes, large volume wearable injectors and other types of devices), service focus area(s), (particle testing, performance testing, and product development), types of service(s) offered (chemical characterization / testing, closure integrity testing, packaging validation, process development and validation, stability studies and other types of services), and number of accreditations / certifications.

Elaborate profiles of key players that offer services for development and testing of combination products. Each profile features a brief overview of the company, along with information on year of establishment, location of headquarters, number of employees, key executives, recent developments and an informed future outlook.

A detailed analysis of the recent expansions undertaken by various combination product service providers, based on several relevant parameters, such as year of expansion, type of expansion (capacity expansions, facility expansions and new facility addition), location of expanded facility, most active players (in terms of number of recent expansions) and geographical distribution.

A case study on most advanced and popular combination products, including large volume wearable injectors and prefilled syringes combination products, providing information on their developer(s) and combination product specific features. Details of specific parameters captured for different product categories are mentioned as follows:

Large Volume Wearable Injector Combination Products: These products have been analyzed based on phase of development, type of device, drug compatibility, type of dosage, route of administration, method of administration, therapeutic area, storage volume / capacity, usability, technology used, mechanism of action and type of drug container.

Prefilled Syringe Combination Products: These therapies that have been approved / are being developed in combination with prefilled syringes have been analyzed based on type of drug molecule, year of approval (for approved therapies), geography (for approved therapies), route of administration, therapeutic area, dose strength (for approved therapies), and other available dosage forms (for approved therapies).

A list of more than 90 combination product developers that are likely to partner with combination product service providers (with regard to likely collaboration opportunities for combination product development and testing). These players have been shortlisted based on various parameters, such as pipeline strength, developer strength and product strength.

An insightful outsourcing: go or no go framework analysis, highlighting the various factors that need to be taken into consideration by combination product developers while deciding whether to develop their respective products in-house or engage the services of a service provider. Further, the analysis highlights all the key parameters that must be considered by players based on company sizes (very small, small, mid-sized, and large), while taking the aforementioned decision.

Key Questions Answered

Who are the key players that provide services for the development and testing of combination products?
What are the most common services offered by combination product service providers?
What are the different types of expansion initiatives being undertaken by combination product service providers?
Who are the leading players that are currently engaged in the development / commercialization of combination products?
What are the most advanced features of combination products?
Which factors are likely to influence the decision of combination product developers for outsourcing development and testing operations?
How is the current and future market opportunity likely to be distributed across key market segments?

Key Topics Covered:

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Combination Products
3.3. Challenges Associated with Development of Combination Products
3.4. Outsourced Combination Products Operations / Services
3.5. Advantages of Outsourcing Operations for Combination Products
3.6. Key Considerations while Selecting a CDMO
3.7. Future Perspectives

4. COMBINATION PRODUCTS SERVICE PROVIDERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Combination Products Service Providers: Overall Market Landscape

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions / Key Parameters
5.3. Methodology
5.4. Combination Products Service Providers: Company Competitiveness Analysis

6. COMBINATION PRODUCTS SERVICE PROVIDERS: COMPANY PROFILES
6.1. Chapter Overview
6.2. EKG LABS
6.2.1. Company Overview
6.2.2. Recent Developments and Future Outlook
6.3. Eurofins Medical Device Testing
6.4. Exponent
6.5. Kymanox
6.6. Medical Engineering Technologies
6.7. Pace Analytical Services
6.8. Suttons Creek
6.9. West Pharmaceutical Services
6.10. Concluding Remarks: Initiatives Undertaken by Industry Players

7. RECENT EXPANSIONS
7.1. Chapter Overview
7.2. Combination Products Service Providers: List of Recent Expansions

8. CASE STUDY: LARGE VOLUME WEARABLE INJECTORS AND PREFILLED SYRINGES COMBINATION PRODUCTS
8.1. Chapter Overview
8.2. Large Volume Wearable Injector Combination Products
8.3. Prefilled Syringes Combination Products

9. LIKELY PARTNER ANALYSIS
9.1. Chapter Overview
9.2. Large Volume Wearable Injectors Combination Products
9.3. Prefilled Syringes Combination Products

10. OUTSOURCING: GO / NO-GO FRAMEWORK
10.1. Chapter Overview
10.2. Outsourcing: Go / No-Go Framework
10.3. Prefilled Syringes Combination Products Developers: Go / No-Go Framework

11. MARKET FORECAST
11.1. Chapter Overview
11.2. Key Assumptions and Forecast Methodology
11.3. Global Combination Products Service Providers Market, 2022-2035
11.3.1. Global Combination Products Service Providers Market: Distribution by Type of Device, 2022 and 2035
11.3.2. Global Combination Products Service Providers Market: Distribution by Service Focus Area, 2022 and 2035
11.3.3. Global Combination Products Service Providers Market: Distribution by Company Size, 2022 and 2035
11.3.4 Combination Products Service Providers Market: Distribution by Region, 2022 and 2035

12. CONCLUDING REMARKS

13. EXECUTIVE INSIGHTS

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Angiplast
3M
Abbott Laboratories
AbbVie
Accord Healthcare
Adamis Pharmaceuticals
Adimmune
Alder BioPharmaceuticals
Alkermes
Alvogen
Alvotech
Amgen
Amgen
Amphastar Pharmaceuticals
anteris medical
Apobiologix
Asarina Pharma
AstraZeneca
B.Braun
Basic Laboratory
BD
Bio-Concept Laboratories
Biogen
Bioinova
Boehringer Ingelheim
Bone Therapeutics
Braeburn Pharmaceuticals
Bristol-Myers Squibb
Camurus
Celltrion
Centrexion Therapeutics
Chugai Pharmaceuticals
Coherus BioSciences
Con-Test Analytical Laboratory (Acquired by Pace Analytical Services)
Cumberland Pharmaceuticals
Cycle Pharmaceuticals
DDL
Department of Defense
Drug Delivery Experts
Dynavax Technologies
EdgeOne Medical
EKG Labs
Element Materials Technology
Eli Lilly
EMD Serono
Emerson Resources (Acquired by Pace Analytical Services)
Eurofins Medical Device Testing
EVER Pharma
Exemplar Compliance
Exponent
Foresee Pharmaceuticals
Fresenius Kabi
Fujifilm
GC Pharma
GENERON
Genetech
Genmab
Gerresheimer
Gilero
GlaxoSmithKline
Glenmark Pharmaceuticals
Hanmi Pharmaceutical
Heron Therapeutics
Hetero Healthcare
Il-Yang Pharm
Insulet
Ipsen
IWA Consulting
Janssen
Kiniksa Pharmaceuticals
Kymanox
Kyowa Kirin
Salvat Laboratories
LEO Pharma
Lubrizol Life Science
Lundbeck
Medicago
Medical Engineering Technologies
MEDIcept
Merck
Milfra (Acquired by Nemera)
Mithra Pharmaceuticals
Mitsubishi Tanabe Pharma
Momenta Pharmaceuticals
MorphoSys
NAMSA
Nelson Labs
NEUMA
NeuroDerm
Nexus Pharmaceuticals
Novartis
Novocol Pharmaceuticals
NubGenix
Oncobiologics
Otsuka Pharmaceutical
Pace Analytical Services
Pfizer
PharmaEssentia
Phillips-Medisize
Piramal Enterprises
PTC Therapeutics
Regeneron
RHEACELL
Roche
Samsung Bioepis
Sandoz
Sanofi
Sanofi Pasteur
scPharmaceuticals
Seqirus
Shire
Special Pathogens Laboratory
Sun Pharma
Surpass
Suttons Creek
Swedish Orphan Biovitrum
Takeda Pharmaceuticals
Teva Pharmaceutical
UCB Biopharma
United Therapeutics
US Department of Health and Human Services
Valeant Pharmaceuticals
Velesco Pharmaceutical Services
Vitaeris
West Pharmaceutical Services
WestView Capital Partners
Wickham Micro
WuXi AppTec
Xeris Pharmaceuticals
YL Biologics
Zealand Pharma
ZebraSci
Zhejiang Huahai Pharmaceutical

For more information about this report visit https://www.researchandmarkets.com/r/4akxsv

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets